Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1.98x is 54% above its 5-year average of -4.28x, around the middle of its 5-year range (-9.81x–5.91x).
12.32% below its 12-month average of -1.76x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -1.71x.
INTEREST COVERAGE RATIO
-1.98x
INTEREST COVERAGE RATIO AVG TTM
-1.76x
INTEREST COVERAGE RATIO AVG 3Y
-3.24x
INTEREST COVERAGE RATIO AVG 5Y
-4.28x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-12.32%
CURRENT VS 3Y AVG
+38.96%
CURRENT VS 5Y AVG
+53.73%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
+65.80%
vs the sector median at left
Karyopharm Therapeutics Inc.
Market Cap
$16.08M
Interest Coverage Ratio
-1.98x
TTM Avg
-1.76x
3Y Avg
-3.24x
5Y Avg
-4.28x
Market Cap
$16.50M
Interest Coverage Ratio
-15.67x
TTM Avg
0.81x
3Y Avg
0.81x
5Y Avg
0.81x
Market Cap
$15.59M
Interest Coverage Ratio
-68.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.64M
Interest Coverage Ratio
-111.88x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.14M
Interest Coverage Ratio
-1288.77x
TTM Avg
51.73x
3Y Avg
51.73x
5Y Avg
51.73x
Market Cap
$15.25M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.01M
Interest Coverage Ratio
N/A
TTM Avg
1.00x
3Y Avg
1.00x
5Y Avg
1.00x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | $16.08M | -1.98x | -1.76x | -3.24x | -4.28x |
| BioCardia, Inc. (BCDA)vs › | $15.85M | N/A | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.50M | -15.67x | 0.81x | 0.81x | 0.81x |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.59M | -68.14x | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | -111.88x | N/A | N/A | N/A |
| Palatin Technologies, Inc. (PTN)vs › | $17.14M | -1288.77x | 51.73x | 51.73x | 51.73x |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.25M | N/A | N/A | N/A | N/A |
| PAVmed Inc. (PAVM)vs › | $17.27M | -1038.38x | N/A | N/A | N/A |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | N/A | 1.00x | 1.00x | 1.00x |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.85M | N/A | N/A | N/A | N/A |
Interest Coverage
-2.0x
Debt/Equity
N/A
Current Ratio
0.79
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -1.71x |
| 2026-03-31 | -2.13x |
| 2025-12-31 | -1.41x |
| 2025-09-30 | -1.38x |
| 2025-06-30 | -2.17x |
| 2025-03-31 | -3.02x |
| 2024-12-31 | -2.79x |
| 2024-09-30 | -2.31x |
| 2024-06-30 | -3.14x |
| 2024-03-31 | -5.74x |
| 2023-12-31 | -6.09x |
| 2023-09-30 | -5.15x |
| 2023-06-30 | -5.11x |
| 2023-03-31 | -5.37x |
| 2022-12-31 | -5.76x |
| 2022-09-30 | -5.04x |
| 2022-06-30 | -6.80x |
| 2022-03-31 | -5.17x |
| 2021-12-31 | 5.91x |
| 2021-09-30 | -5.47x |
| 2021-06-30 | -9.81x |
| 2021-03-31 | -10.28x |
| 2020-12-31 | -5.24x |
| 2020-09-30 | -6.93x |
| 2020-06-30 | -5.97x |
| 2020-03-31 | -7.28x |
| 2019-12-31 | -6.69x |
| 2019-09-30 | -12.74x |
| 2019-06-30 | -13.49x |
| 2019-03-31 | -21.66x |
| 2018-12-31 | -23.05x |
